Cost of disease-modifying therapies for multiple sclerosis continues to rise in US
Pharmaceutical Technology
MAY 19, 2023
DMTs for MS have a high price tag, particularly in the US. This economic burden may deter some patients from seeking treatment, while others might decide to stop taking their treatment altogether. However, they cannot provide a cure and have a very limited impact on halting disease progression.
Let's personalize your content